Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Other Non Operating Income (2017 - 2026)

Inspire Medical Systems' Other Non Operating Income history spans 10 years, with the latest figure at -$226000.0 for Q1 2026.

  • On a quarterly basis, Other Non Operating Income fell 139.1% to -$226000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$3.5 million, a 1494.47% decrease, with the full-year FY2025 number at -$2.7 million, down 210.64% from a year prior.
  • Other Non Operating Income hit -$226000.0 in Q1 2026 for Inspire Medical Systems, down from $330000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for INSP hit a ceiling of $578000.0 in Q1 2025 and a floor of -$3.5 million in Q2 2025.
  • Historically, Other Non Operating Income has averaged -$234176.5 across 5 years, with a median of -$61000.0 in 2023.
  • The widest YoY moves for Other Non Operating Income: up 1063.33% in 2025, down 2491.11% in 2025.
  • Tracing INSP's Other Non Operating Income over 5 years: stood at $241000.0 in 2022, then plummeted by 69.71% to $73000.0 in 2023, then crashed by 1165.75% to -$778000.0 in 2024, then soared by 142.42% to $330000.0 in 2025, then plummeted by 168.48% to -$226000.0 in 2026.
  • Business Quant data shows Other Non Operating Income for INSP at -$226000.0 in Q1 2026, $330000.0 in Q4 2025, and -$66000.0 in Q3 2025.